Thromb Haemost 1971; 25(02): 288-296
DOI: 10.1055/s-0038-1654303
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

Protection by Aspirin against Experimentally Induced Arterial Thrombosis in Dogs

C. A Danese M. D.
*   Dept. of Surgery, The Mount Sinai School of Medicine, New York, N. Y.
,
Ch D. Voleti M. D.
*   Dept. of Surgery, The Mount Sinai School of Medicine, New York, N. Y.
,
H. J Weiss M. D.
**   Division of Hematology (Dept. of Medicine), The Roosevelt Hospital, New York, N. Y.
› Author Affiliations
Dr. Weiss is a Career Scientist of the Health Research Council of the City of New York. This study was supported, in part, by the John A. Hartford Foundation.
Further Information

Publication History

Publication Date:
24 July 2018 (online)

Summary

The possible anti-thrombotic properties of drugs which interfere with platelet aggregation were studied. Segments of the peripheral arteries of dogs were isolated, injured either by endarterectomy or chemically by instillation of 0.1 N H2 S04 (chemical injury). Two days later, the segments were examined for the presence of thrombosis. In animals which received only a placebo, 29% of the chemically-injured segments and 43% of the endarterectomized segments became totally occluded with thrombi. Treatment with aspirin (600 mg per day) reduced this incidence to 2 and 11% respectively (p < .05) while treatment with dipyridamole (DPM) (200 mg per day) had no effect. In a second study, aspirin ingestion reduced the incidence of total occlusion in chemically-injured segments from 38 to 0%. Connective-tissue induced platelet aggregation decreased in aspirin treated animals, while DPM had no effect. The findings support previous suggestions that aspirin, perhaps by inhibiting platelet aggregation, has anti-thrombotic properties.

 
  • References

  • 1 Gifford R. H, Feinstein A. R. A critique of methodology in studies of anticoagulant therapy for acute myocardial infarction. N. Engl. J. Med 280: 351 1969;
  • 2 Salzman E. W, Britten A. Hemorrhage and Thrombosis. Littele, Brown & Co; Boston: 1969: 197.
  • 3 Glynn M. F, Murphy E. A, Mustard J. F. Platelets and thrombosis. Ann. intern. Med 64: 715 1966;
  • 4 O’Brien J. R, Shoobridge S. M, Finch W. J. Comparison of the effect of heparin and citrate on platelet aggregation. J. clin. Path 22: 28 1969;
  • 5 Weiss H. J, Aledort L. M. Impaired platelet-connective tissue reaction in man produced by aspirin ingestion. Lancet II: 495 1969;
  • 6 Weiss H. J, Aledort L. M, Kochwa S. The effect of salicylates on the hemostatic properties of platelets in man. J. clin. Inv 47: 2169 1968;
  • 7 O’Brien J. R. Effects of salicylates on human platelets. Lancet I: 779 1969;
  • 8 Quick A. J. Salicylates and bleeding: the aspirin tolerance test. Amer. J. med. Sci 252: 265 1967;
  • 9 Mielke C. H, Kaneshiro M. M, Maher I. A, Weiner J. M, Rapaport S. I. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 34: 204 1969;
  • 10 Sullivan J. M, Harken D. E, Gorlin R. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. N. Engl. J. Med 279: 576 1968;
  • 11 Emmons P. R, Harrison M. J, Honour A. J, Mitchell J. R. A. Effect of a pyrimidopyrimidine durative on thrombus formation in the rabbit. Nature 208: 255 1965;
  • 12 Didisheim P. Inhibition by dipyridamole of arterial thrombosis in rats. Thrombos. Diathes. haemorrh. (Stuttg) 20: 257 1969;
  • 13 Deaton H. L, Anlyan W. O. A study of experimental methods for producing thrombosis in small arteries. Surg. Gynec. Obstet Ill: 131 1960;
  • 14 Suarez E. L, Jacobson J. H. Results of small artery endarterectomy-microsurgical technique. Surgical Forum 12: 1961 1961;
  • 15 Whitman N. L, Skohl T, Barker W. F. Prevention of arterial thrombosis following experimental endarterectomy with plasmin (fibrinolysin). Ann. Surg 153: 533 1961;
  • 16 Evans G. E, Packham M. A, Nishizawa E. E, Mustard J. F, Murphy E. A. The effect of acetylsalicylic acid on platelet function. J, exp. Med 128: 877 1968;
  • 17 Zucker M. B, Peterson J. B. Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion. Proc. Soc. exp. Biol. (N. Y) 127: 547 1968;
  • 18 Arfors K. E, Hint H. G, Dhall D. P, Matheson N. A. Counteraction of platelet activity at sites of laserinduced and endothelial trauma. Brit. med. J 04: 430 1968;
  • 19 Philp R. B, Lemieux V. Comparison of some effects of dipyridamole and adenosine on thrombus formation, platelet adhesiveness and blood pressure in rabbits and rats. Nature 218: 1072 1968;
  • 20 Browse N. L, Hall J. H. Effect of dipyridamole on the incidence of clinically detectable deep-vein thrombosis. Lancet II: 718 1969;
  • 21 Weiss H. J. Aspirin ingestion compared with bleeding disorders — search for a useful platelet anti-aggregant. Blood 35: 333 1970;